Efficacy of Tramadol With Ropivacaine for Modified Pectoral Nerve Block in Breast Cancer Surgery

What this study involves

The registry does not currently label this study as recruiting. Ask about its status before planning a screening visit.

Study type

Interventional

Phase

Not applicable

Age range

20 years - 70 years

Sex eligible

All sexes

Healthy volunteers

Accepted

Participants

62 Actual

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

In this study the investigators will compare the post operative opoid consumption for patient undergoing modified radical mastectomy. The patients will be divided into two groups one group will receive modified pectoral nerve block with local anesthetic ropivacaine combined with tramadol and other group will receive pectoral nerve block with ropivacaine only

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

1. Female Patients aged 20-70 years
2. Patients scheduled for elective unilateral modified radical mastectomy
3. Patients with ASAI andII physical status.

Exclusion Criteria:

1. Patients on anticoagulant therapy.
2. Patients with a BMI≥35 kg/m3.
3. Patients with a history of allergy to local anesthetics.
4. Patients with significant neurological or psychiatric disorders.
5. Pregnant patients.

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment

Random assignment

Masking

Quadruple masked

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Research locations (1)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

1 locations

Study team and timeline

Lead sponsor

Sargodha Medical College

Study start

Jan 22, 2026 Actual

Primary completion

Mar 19, 2026 Actual

Study completion

Mar 19, 2026 Actual

First posted

Aug 20, 2026 Actual

Last updated

Nov 10, 2026 Actual

Official study contacts

No central contact is listed. Check the locations and the official record.